title: AML 2647

value: blasts and mononuclear cells

value: male

value: 22 years

value: FAB M4E

value: Pos


title: AML 2525

status: Public on Mar 12 2008

type: RNA

city: Houston

first: Roel

last: Verhaak

state: TX

address: 1400 Pressler St

department: Bioinformatics and Comp Bio

country: USA

institute: MD Anderson Cancer Center

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.

hyb_protocol: Affymetrix protocol.

scan_protocol: Affymetrix protocol.

data_processing: MAS5 with global scaling to target value 100, followed by setting all values lower than 30 at 30, and then log2 transformation.

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: Blasts and mononuclear cells, AML patient

label_protocol: Affymetrix protocol.

extract_protocol: Total RNA was extracted by lysis with guanidium isothiocyanate followed by cesium chloride gradient purification.

tag: disease state

value: Acute myeloid leukemia

tag: cell type

value: pos

value: neg

tag: gender

value: female

tag: age

value: 53 years

tag: score

value: FAB M5

tag: risk

value: cytogenetic intermediate

tag: cebpa

value: wild type

tag: karyotype

value: NN

tag: flt3 itd mutation

value: Neg

tag: flt3 tkd mutation

tag: n-ras mutation

tag: k-ras mutation

tag: evi1 expression

tag: cebpa mutation


title: AML 2516

value: 51 years

value: FAB M3

value: cytogenetic good


title: AML 2524

value: blasts and mononuclear cells

value: male

value: FAB M1


title: AML 2510

value: 26 years

value: Pos


title: AML 2511

value: Acute myeloid leukemia

value: 35 years

value: FAB M2


title: AML 2541

value: neg

value: female

value: 56 years

value: cytogenetic poor


title: AML 2498

value: 59 years

value: FAB M4

value: wild type


title: AML 2514

value: 34 years

value: FAB M5

value: Neg


title: AML 2497

value: blasts and mononuclear cells

value: male

value: 20 years

value: cytogenetic intermediate

value: Other


title: AML 2490

value: Acute myeloid leukemia

value: FAB M6

value: NN

value: Pos


title: AML 2507

value: neg

value: female

value: 48 years

value: FAB M2


title: AML 2509

value: 35 years

value: FAB M3

value: cytogenetic good

value: wild type


title: AML 2467

value: blasts and mononuclear cells

value: 44 years

value: FAB M5

value: Neg


title: AML 3293

value: 36 years

value: cytogenetic intermediate


title: AML 2466

value: Acute myeloid leukemia

value: 39 years


title: AML 2304

value: 56 years

value: FAB M0

value: cytogenetic poor

value: Other


title: AML 2297

value: neg

value: female

value: 37 years

value: Pos


title: AML 2307

value: 48 years

value: FAB M3

value: cytogenetic good

value: wild type


title: AML 2292

value: blasts and mononuclear cells

value: male

value: FAB M5

value: Neg


title: AML 2480

value: Acute myeloid leukemia

value: 34 years

value: FAB M1

value: cytogenetic intermediate

value: NN


title: AML 2468

value: neg


title: AML 2301

value: 24 years

value: failure


title: AML 2300

value: pos

value: female

value: 56 years

value: Pos


title: AML 2279

value: 54 years

value: FAB M4

value: wild type


title: AML 2293

value: blasts and mononuclear cells

value: 57 years

value: cytogenetic good


title: AML 2296

value: Acute myeloid leukemia

value: male

value: 38 years

value: FAB M5

value: Neg


title: AML 2306

value: neg

value: 35 years

value: FAB M1

value: cytogenetic intermediate

value: NN


title: AML 2326

value: 30 years

value: FAB M2

value: cytogenetic poor

value: Pos


title: AML 2280

value: blasts and mononuclear cells

value: female

value: 49 years

value: wild type


title: AML 2302

value: Acute myeloid leukemia

value: pos

value: 34 years

value: Other


title: AML 2299

value: neg

value: male

value: 39 years

value: Neg


title: AML 322

value: 43 years

value: FAB M3

value: cytogenetic good


title: AML 2285

value: 17 years

value: FAB M5

value: cytogenetic poor


title: AML 2290

value: blasts and mononuclear cells

value: female

value: 41 years

value: FAB M2

value: cytogenetic intermediate


title: AML 2289

value: Acute myeloid leukemia

value: 50 years

value: wild type

value: NN

value: Pos


title: AML 2288

value: neg

value: male

value: 31 years

value: FAB M4

value: Neg


title: AML 2287

value: 16 years

value: cytogenetic good


title: AML 2286

value: blasts and mononuclear cells

value: 35 years

value: FAB M1


title: AML 2281

value: 20 years


title: AML 2291

value: 49 years

value: FAB M5

value: cytogenetic intermediate


title: AML 2284

value: Acute myeloid leukemia

value: 32 years

value: FAB M6

value: wild type


title: AML 2274

value: neg

value: female

value: 46 years

value: NN


title: AML 2278

value: 45 years

value: Pos

value: Neg


title: AML 2273

value: blasts and mononuclear cells

value: male

value: 16 years

value: double mutant


title: AML 2265

value: 21 years

value: FAB M3

value: cytogenetic good


title: AML 2263

value: Acute myeloid leukemia

value: 31 years


title: AML 2272

value: 35 years

value: FAB M5

value: cytogenetic poor

value: wild type


title: AML 2282

value: pos

value: neg

value: 44 years

value: FAB M4

value: cytogenetic intermediate

value: NN


title: AML 2268

value: blasts and mononuclear cells

value: male

value: 56 years

value: FAB M1

value: Pos

value: Neg


title: AML 2271

value: Acute myeloid leukemia

value: female

value: 43 years

value: FAB M2


title: AML 2267

value: 29 years

value: cytogenetic good

value: wild type


title: AML 2275

value: neg

value: 46 years

value: FAB M5


title: AML 2262

value: 39 years


title: AML 2266

value: blasts and mononuclear cells

value: 58 years

value: FAB M3


title: AML 2252

value: 27 years

value: cytogenetic intermediate

value: NN


title: AML 2270

value: Acute myeloid leukemia

value: male

value: 41 years

value: FAB M1

value: Pos

value: Neg


title: AML 2256

value: 51 years

value: FAB M2

value: wild type


title: AML 2198

value: neg

value: FAB M5


title: AML 2253

value: blasts and mononuclear cells

value: 43 years

value: double mutant


title: AML 2259

value: 18 years

value: FAB M4

value: cytogenetic poor

value: Complex


title: AML 2261

value: Acute myeloid leukemia

value: female

value: 37 years

value: cytogenetic intermediate

value: NN


title: AML 2257

value: male

value: 40 years

value: FAB M1

value: Neg


title: AML 2197

value: neg

value: 24 years

value: FAB M2

value: cytogenetic good

value: wild type

value: Pos


title: AML 2254

value: blasts and mononuclear cells

value: 23 years

value: FAB M4


title: AML 2260

value: Acute myeloid leukemia

value: 18 years

value: FAB M5


title: AML 2255

value: 44 years

value: cytogenetic poor


title: AML 2196

value: male

value: 19 years

value: cytogenetic intermediate

value: NN


title: AML 2189

value: neg

value: 53 years

value: FAB M4E

value: Neg


title: AML 2195

value: 49 years

value: wild type

value: Pos


title: AML 2188

value: blasts and mononuclear cells

value: pos

value: 51 years

value: FAB M2

value: single mutant


title: AML 2194

value: Acute myeloid leukemia

value: female

value: 20 years

value: FAB M4


title: AML 2193

value: 50 years

value: FAB M1

value: cytogenetic intermediate

value: NN


title: AML 2187

value: neg

value: Neg


title: AML 2182

value: FAB M5

value: wild type


title: AML 2184

value: blasts and mononuclear cells

value: male

value: 47 years

value: Other


title: AML 2192

value: 45 years

value: double mutant

value: Pos


title: AML 2190

value: Acute myeloid leukemia

value: 15 years

value: cytogenetic poor


title: AML 2179

value: female

value: 53 years

value: FAB M4

value: cytogenetic good


title: AML 2183

value: neg

value: 52 years

value: cytogenetic intermediate

value: NN

value: Neg


title: AML 2177

value: blasts and mononuclear cells

value: 18 years

value: FAB M2

value: wild type


title: AML 2181

value: 39 years

value: FAB M5

value: Pos


title: AML 2178

value: Acute myeloid leukemia

value: male

value: 46 years


title: AML 2176

value: 41 years

value: FAB M4

value: single mutant


title: AML 2186

value: neg

value: cytogenetic poor


title: AML 2185

value: female

value: 50 years

value: cytogenetic intermediate

value: NN


title: AML 2174

value: blasts and mononuclear cells

value: 45 years

value: Neg


title: AML 2175

value: 57 years

value: FAB M5

value: wild type


title: AML 1766

value: Acute myeloid leukemia

value: pos

value: male

value: 52 years

value: FAB unknown

value: Pos


title: AML 1747

value: neg

value: 59 years

value: FAB M2


title: AML 1551

value: female

value: 43 years

value: FAB M1

value: cytogenetic intermediate


title: AML 2171

value: blasts and mononuclear cells

value: 40 years

value: FAB M4

value: Other

value: Neg


title: AML 1432

value: Acute myeloid leukemia

value: pos

value: 53 years

value: wild type

value: NN


title: AML 1299

value: neg

value: 32 years

value: Pos


title: AML 2172

value: male

value: 18 years

value: cytogenetic good


title: AML 1188

value: female

value: 33 years

value: FAB M1

value: cytogenetic poor


title: AML 2327

value: blasts and mononuclear cells

value: 54 years

value: FAB M2


title: AML 1197

value: Acute myeloid leukemia

value: 51 years

value: FAB M0

value: Complex

value: Neg


title: AML 1595

value: neg

value: 43 years

value: cytogenetic intermediate

value: wild type

value: NN


title: AML 2169

value: male

value: 60 years

value: double mutant

value: Pos


title: AML 1316

value: blasts and mononuclear cells

value: 19 years

value: FAB M1


title: AML 1174

value: Acute myeloid leukemia

value: female

value: 59 years

value: FAB M5


title: AML 2205

value: 33 years

value: FAB M2

value: cytogenetic poor

value: Neg


title: AML 2250

value: neg

value: 18 years

value: wild type


title: AML 2249

value: 29 years

value: cytogenetic good


title: AML 2170

value: male

value: 54 years

value: FAB M3

value: Pos


title: AML 2217

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: 53 years

value: cytogenetic intermediate


title: AML 2251

value: female

value: 55 years

value: Complex


title: AML 2248

value: FAB M1

value: NN

value: Neg


title: AML 2245

value: neg

value: 47 years

value: FAB M2

value: wild type


title: AML 2244

value: male

value: 51 years

value: FAB M5

value: cytogenetic poor


title: AML 2243

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: 26 years

value: cytogenetic good


title: AML 2236

value: female

value: 36 years

value: cytogenetic intermediate

value: Pos


title: AML 2241

value: 53 years

value: FAB M4

value: NN

value: Neg


title: AML 2237

value: neg

value: 57 years

value: FAB M1

value: single mutant


title: AML 2242

value: 54 years

value: double mutant


title: AML 2233

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: pos

value: 59 years

value: cytogenetic poor

value: wild type


title: AML 2240

value: male

value: 48 years

value: cytogenetic intermediate

value: Pos


title: AML 2230

value: female

value: 37 years

value: FAB M2

value: NN

value: Neg


title: AML 2246

value: neg

value: 33 years

value: FAB M1


title: AML 2227

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: 34 years

value: FAB M5


title: AML 2238

value: 21 years

value: wild type


title: AML 2247

value: 47 years

value: Other


title: AML 2229

value: pos

value: male

value: 43 years

value: FAB M4

value: cytogenetic poor


title: AML 2239

value: female

value: 48 years

value: cytogenetic intermediate

value: NN

value: Pos

value: Neg


title: AML 2224

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: neg

value: 45 years

value: FAB M6

tag: karyotype:


title: AML 2228

value: 41 years

value: wild type


title: AML 2234

value: male

value: 37 years

value: FAB M2

value: double mutant

value: Other


title: AML 2235

value: female

value: 59 years

value: FAB M4

value: cytogenetic good


title: AML 2226

value: pos

value: 33 years

value: FAB M1

value: cytogenetic intermediate

value: Neg

value: Pos


title: AML 2223

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: neg

value: 54 years


title: AML 2225

value: male

value: 47 years

value: wild type

value: NN


title: AML 2231

value: female

value: 43 years


title: AML 2220

value: 48 years

value: FAB M5

value: Other


title: AML 2215

value: 31 years

value: FAB M4

value: cytogenetic good


title: AML 2218

value: pos

value: 40 years

value: FAB M1

value: cytogenetic intermediate

value: double mutant

value: Neg

value: Pos


title: AML 2216

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: neg

value: 58 years

value: wild type


title: AML 2222

value: female

value: 53 years

value: NN


title: AML 2219

value: 31 years

value: FAB M3


title: AML 2210

value: male

value: 37 years

value: FAB M2

value: cytogenetic good


title: AML 2208

value: 48 years


title: AML 2206

value: 50 years

value: FAB M5

value: cytogenetic intermediate

value: Neg


title: AML 2207

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: neg

value: 30 years

value: FAB M1

value: cytogenetic poor

value: Pos


title: AML 2204

value: wild type


title: AML 2214

value: female

value: 25 years

value: NN


title: AML 2209

value: 55 years

value: FAB M4

value: Other


title: AML 2203

value: pos

value: male

value: 37 years


title: AML 2211

value: Acute myeloid leukemia

value: 28 years

value: FAB M2

value: cytogenetic good

value: Neg


title: AML 2200

value: blasts and mononuclear cells

value: neg

value: 38 years


title: AML 2199

value: 54 years

value: FAB M1

value: cytogenetic intermediate

value: wild type

value: Pos


title: AML 2201

value: female

value: 33 years

value: FAB M5

value: NN


title: AML 2202

value: Acute myeloid leukemia

value: 35 years

value: FAB M4E


title: O#96

status: Public on Feb 15 2008

city: New York

first: Deepa

last: Bhojwani

state: NY

address: Smilow Research Building 1206-B, 522 First Avenue

department: Pediatric Hematology Oncology

institute: New York University School of Medicine

description: Relapse: patients that relapsed within 3 years of initial diagnosis

scan_protocol: M10 scanner, Pixel size 1.56, Filter 570

data_processing: MAS 5.0

source_name: bone marrow

label_protocol: Enzo BioArray HighYield RNA transcript labeling kit

extract_protocol: Qiagen Rneasy

tag: Male, 208 months of age


title: O#98

description: CCR: continuous complete remission for > 4 years

tag: Female, 189 months of age


title: O#95

tag: Male, 126 months of age


title: O#92

tag: Male, 213 months of age


title: O#97

tag: Male, 152 months of age


title: O#93

tag: Male, 138 months of age


title: O#89

tag: Male, 146 months of age


title: O#91

tag: Male, 173 months of age


title: O#99

tag: Male, 178 months of age


title: O#90

tag: Female, 148 months of age


title: O#88

tag: Male, 141 months of age


title: O#84

tag: Male, 79 months of age


title: O#86

tag: Male, 36 months of age


title: O#87

tag: Female, 146 months of age


title: O#85

tag: Male, 27 months of age


title: O#80

description: SER: slow early responder = patient with M3 marrow at Day 7, CCR: continuous complete remission for > 4 years

tag: Male, 75 months of age


title: O#77

description: RER: rapid early responder = patient with M1 marrow at Day 7

tag: Male, 214 months of age


title: O#82

tag: Female, 19 months of age


title: O#75


title: O#76

description: SER: slow early responder = patient with M3 marrow at Day 7

tag: Male, 80 months of age


title: O#79

description: SER: slow early responder = patient with M3 marrow at Day 7; Relapse: patients that relapsed within 3 years of initial diagnosis

tag: Male, 153 months of age


title: O#73

description: RER: rapid early responder = patient with M1 marrow at Day 7; CCR: continuous complete remission for > 4 years

tag: Male, 169 months of age


title: O#78

tag: Female, 158 months of age


title: O#83

tag: Male, 179 months of age


title: O#81

tag: Male, 191 months of age


title: O#68

tag: Female, 116 months of age


title: O#65

tag: Female, 109 months of age


title: O#63

tag: Male, 12 months of age


title: O#71

tag: Male, 188 months of age


title: O#74

tag: Male, 106 months of age


title: O#70

tag: Male, 183 months of age


title: O#64

tag: Male, 135 months of age


title: O#69

description: RER: rapid early responder = patient with M1 marrow at Day 7; Relapse: patients that relapsed within 3 years of initial diagnosis


title: O#67

tag: Male, 199 months of age


title: O#59

tag: Male, 101 months of age


title: O#66

tag: Male, 189 months of age


title: O#62

tag: Female, 125 months of age


title: O#60

tag: Male, 40 months of age


title: O#72

tag: Female, 126 months of age


title: O#61

tag: Male, 225 months of age


title: O#58

tag: Male, 139 months of age


title: O#55

tag: Female, 41 months of age


title: O#57

tag: Female, 29 months of age


title: O#53

tag: Male, 193 months of age


title: O#54

tag: Female, 185 months of age


title: O#47

tag: Male, 52 months of age


title: O#56

tag: Male, 83 months of age


title: O#49

tag: Male, 39 months of age


title: O#50

tag: Male, 109 months of age


title: O#42

tag: Female, 129 months of age


title: O#46

tag: Male, 176 months of age


title: O#41

tag: Male, 126 months of age


title: O#44


title: O#48

tag: Male, 70 months of age


title: O#51

tag: Male, 128 months of age


title: O#39

tag: Female, 136 months of age


title: O#52

tag: Male, 158 months of age


title: O#43

tag: Male, 177 months of age


title: O#34

tag: Female, 39 months of age


title: O#32

tag: Female, 14 months of age


title: O#35

tag: Male, 66 months of age


title: O#30


title: O#31

tag: Female, 117 months of age


title: O#37

tag: Male, 154 months of age


title: O#38

tag: Female, 50 months of age


title: O#40

tag: Female, 125 months of age


title: O#94

tag: Male, 125 months of age


title: O#36

tag: Female, 150 months of age


title: O#33

tag: Male, 213 months of age


title: O#29

tag: Female, 16 months of age


title: O#28


title: O#15

tag: Male, 202 months of age


title: O#26

tag: Female, 191 months of age


title: O#27

tag: Male, 34 months of age


title: O#21

tag: Female, 129 months of age


title: O#22

tag: Female, 209 months of age


title: O#18

tag: Female, 31 months of age


title: O#17

tag: Female, 18 months of age


title: O#12


title: O#25

tag: Male, 144 months of age


title: O#13

tag: Male, 61 months of age


title: O#23

tag: Male, 133 months of age


title: O#19

tag: Female, 171 months of age


title: O#16

tag: Male, 80 months of age


title: O#20

tag: Male, 177 months of age


title: O#9

tag: Female, 19 months of age


title: O#24

tag: Female, 134 months of age


title: O#8

tag: Male, 118 months of age


title: O#14

tag: Male, 187 months of age


title: O#11

tag: Female, 198 months of age


title: O#7

tag: Female, 132 months of age


title: O#10

tag: Female, 27 months of age


title: O#6

tag: Female, 161 months of age


title: O#3

tag: Male, 25 months of age


title: O#4

tag: Male, 170 months of age


title: O#5

tag: Female, 208 months of age


title: 585686

status: Public on Feb 12 2008

city: St Louis

first: Jacqueline

last: Payton

state: MO

address: 4320 Forest Park Avenue, Suite 211

institute: Washington University School of Medicine

description: A study that used high-throughput re-sequencing of the kinase domains of 26 Tyrosine kinase genes that are expressed in most acute myeloid leukemia patients. Used genomic DNA from bone marrow (tumor).

hyb_protocol: Chips hybridized according to Manufacturer's protocol

data_processing: Data scaled to array mean of 1500

source_name: Bone marrow specimen from Tumor cells

label_protocol: Chips labeled with biotin according to Manufacturer's protocol

growth_protocol: Bone marrow specimen from Tumor cells

extract_protocol: Trizol reagent standard protocol

tag: fab

tag: Sex

value: M

tag: race

value: C

tag: age on study

tag: cytogenetic change

tag: flt3 d835

tag: flt3 itd

tag: npm1 ins


title: 93C184


title: O#2

tag: Female, 134 months of age


title: O#1

tag: Male, 46 months of age


title: 94C207

value: Other

value: Normal


title: C00784

value: Asian


title: C00574

value: F


title: C002017


title: C001297

value: H


title: 93C290


title: O#45

tag: Male, 167 months of age


title: C98430


title: 94C024


title: 93C287


title: C99558


title: C97509

value: AA


title: 94C271


title: C981202


title: C991148


title: C98183


title: 94C240


title: C97408


title: C97464


title: C97651


title: C97286


title: C981301


title: C981252


title: 94C163


title: C00266


title: C95058

value: trisomy 21


title: C00102


title: C981243


title: 93C275


title: C98974


title: C98358


title: C98319


title: C99618


title: C011729


title: C9927


title: C99550


title: C98383


title: C00407


title: C001895


title: C95135


title: 93C57


title: C001539


title: C98354

value: trisomy 10; del(9)(q13q22)


title: C97779


title: C981153

value: Unknown


title: 93C270


title: C991652


title: C99860


title: C98925


title: C99556


title: 94C046


title: C97581


title: 94C149


title: C011143


title: C99901


title: C00111


title: C97529


title: C98412


title: C99508


title: 93C234


title: 93C40


title: C97592


title: C99627


title: C99474


title: C991646


title: C99483


title: C00391


title: C991632


title: C991142


title: C98154


title: C97856


title: C98840


title: 94C022


title: C991255


title: C00205


title: C98110


title: 93C206


title: C98650


title: C99430


title: 494454

value: W

value: -X


title: 93C44


title: C95318


title: C98395


title: C99709


title: C011211


title: C001819


title: C011931


title: C98520

value: trisomy 21; + 22


title: C98804


title: C9967


title: 631879


title: C99934


title: 558395


title: 575512


title: 818119

value: ND


title: C981077

value: trisomy 13; iso(7)(p10)


title: 692900


title: 369065


title: 501944


title: 933124


title: 767545

value: trisomy 11


title: 407992

value: M


title: 104851


title: 156704


title: 104


title: 509733


title: 433325


title: 724606


title: 287


title: 645137


title: 327733


title: 296


title: 537782


title: 301733


title: Patient 55, time point 4

status: Public on Dec 31 2007

city: Vancouver

first: Paul

last: Pavlidis

state: British Columbia

address: 177 Michael Smith Laboratories 2185 East Mall

department: Centre for High-Throughput Biology / Psychiatry

country: Canada

institute: University of British Columbia

description: Patients were recruited among the ones seeking treatment at the clinic for post-doctoral Periodontics, Columbia University College of Dental Medicine. To be eligible for enrollment, patients had to be diagnosed with severe periodontitis, with radiographic evidence of bone loss extending to greater or equal to 30% of the tooth length at several teeth. Additional inclusion criteria required: age greater or equal to 18 years; presence of greater or equal to 2 teeth/quadrant with a pocket depth of greater or equal to 6 mm and concomitant attachment loss of greater or equal to 3 mm; a minimum of 20 teeth present; no prior periodontal therapy; no systemic conditions or genetic disorders that entail the diagnosis of periodontitis as a manifestation of systemic diseases; no use of systemic antibiotics or regular use of anti-inflammatory drugs for the preceding 6-month period; no diabetes mellitus; no current use of tobacco products or of nicotine replacement medication; not currently pregnant. A total of 15 subjects, 7 male and 8 female, were enrolled. All participants were informed about the scope and procedures of the study and informed consent was obtained.

hyb_protocol: According to the manufacturer's instructions.

data_processing: All CEL files in the series were processed using RMA in R using justRMA with default parameters.

source_name: Patient 55 PBMC, collected at time point 4

label_protocol: Synthesis of biotin-labeled cRNA and subsequent fragmentation were performed by the use of the IVT labeling kit (Affymetrix, Santa Clara, CA, USA).  The cRNA yield was determined spectrophotometrically at 260 nm. Fragmented cRNA was stored at -80C until hybridization.

extract_protocol: CD14 positive cells were vigorously pipetted in Trizol (Invitrogen Life Technologies, Carlsbad, CA, USA). After incubation with chloroform and centrifugation at 12,000 g, RNA in the upper aqueous phase was precipitated by mixing with isopropyl alcohol, further centrifugation and washing in 75% ethanol. Further purification of the extracted RNA was achieved by the use of the RNeasy total RNA isolation kit (Qiagen, Valencia, CA, USA) according to the manufacturer.s instructions. The purified RNA was quantified spectrophotometrically. One hundred nanograms of total RNA were amplified and reverse transcribed using the GeneChip expression 3.-amplification two-cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA, USA) and the MEGAscript T7 transcription kit (Ambion, Austin, TX, USA) according to the manufacturers. instructions.

treatment_protocol: Fifty ml of blood were obtained by venipucture and collected in Vacutainer cell preparation tubes (Beckton-Dickinson, NJ, USA) with sodium heparin, and were used to harvest peripheral blood mononuclear cells (PBMCs). A 1:1 dilution with PBS was made and the diluted blood sample was centrifuged at 1,000 g in Ficoll tubes (Sigma Accuspin, St. Louis, MO). After washing and counting of the cells in a phase hemacytometer (Hauser Scientific, Horsham, PA), PBMCs were re-suspended in 80 microlitres of MACS buffer (PBS pH 7.2, 0.5% BSA and 2 mM EDTA) and incubated on ice with 20 microlitres of CD14 microbeads (Miltenyi Biotec, Auburn CA) per 107 total cells for 15 minutes. After washings, the cell suspension was applied to a MACS LS separation column (Miltenyi Biotec) placed in the magnetic field of a MACS separator (Miltenyi Biotec). Thereafter, the column was removed from the separator and CD14 positive cells were collected by washings in MACS buffer.

tag: Time

value: ten weeks after prior to commencement of periodontal therapy (four weeks after treatment end)

tag: Tissue

value: Peripheral blood monocytes

tag: Phenotype

value: severe periodontitis


title: Patient 55, time point 2

scan_protocol: According to the manufacturer's instructions.

source_name: Patient 55 PBMC, collected at time point 2

value: at commencement of periodontal therapy


title: Patient 55, time point 1

source_name: Patient 55 PBMC, collected at time point 1

value: one week prior to commencement of periodontal therapy


title: Patient 54, time point 3

source_name: Patient 54 PBMC, collected at time point 3

value: six weeks after commencement of periodontal therapy (after treatment end)


title: C99325

value: F

value: C

value: Normal


title: 108135


title: Patient 54, time point 2

source_name: Patient 54 PBMC, collected at time point 2


title: Patient 45, time point 4

source_name: Patient 45 PBMC, collected at time point 4


title: Patient 43, time point 4

source_name: Patient 43 PBMC, collected at time point 4


title: Patient 54, time point 4

source_name: Patient 54 PBMC, collected at time point 4


title: Patient 45, time point 1

source_name: Patient 45 PBMC, collected at time point 1


title: 201


title: Patient 45, time point 3

source_name: Patient 45 PBMC, collected at time point 3


title: Patient 45, time point 2

source_name: Patient 45 PBMC, collected at time point 2


title: Patient 54, time point 1

source_name: Patient 54 PBMC, collected at time point 1


title: Patient 43, time point 3

source_name: Patient 43 PBMC, collected at time point 3


title: Patient 40, time point 3

source_name: Patient 40 PBMC, collected at time point 3


title: Patient 40, time point 1

source_name: Patient 40 PBMC, collected at time point 1


title: Patient 38, time point 2

source_name: Patient 38 PBMC, collected at time point 2


title: Patient 40, time point 4

source_name: Patient 40 PBMC, collected at time point 4


title: Patient 38, time point 4

source_name: Patient 38 PBMC, collected at time point 4


title: Patient 43, time point 1

source_name: Patient 43 PBMC, collected at time point 1


title: Patient 38, time point 1

source_name: Patient 38 PBMC, collected at time point 1


title: Patient 55, time point 3

source_name: Patient 55 PBMC, collected at time point 3


title: Patient 43, time point 2

source_name: Patient 43 PBMC, collected at time point 2


title: Patient 40, time point 2

source_name: Patient 40 PBMC, collected at time point 2


title: Patient 38, time point 3

source_name: Patient 38 PBMC, collected at time point 3


title: Patient 35, time point 3

source_name: Patient 35 PBMC, collected at time point 3


title: Patient 36, time point 2

source_name: Patient 36 PBMC, collected at time point 2


title: Patient 36, time point 4

source_name: Patient 36 PBMC, collected at time point 4


title: Patient 32, time point 4

source_name: Patient 32 PBMC, collected at time point 4


title: Patient 36, time point 3

source_name: Patient 36 PBMC, collected at time point 3


title: Patient 29, time point 4

source_name: Patient 29 PBMC, collected at time point 4


title: Patient 32, time point 1

source_name: Patient 32 PBMC, collected at time point 1


title: Patient 35, time point 4

source_name: Patient 35 PBMC, collected at time point 4


title: Patient 29, time point 1

source_name: Patient 29 PBMC, collected at time point 1


title: Patient 32, time point 3

source_name: Patient 32 PBMC, collected at time point 3


title: Patient 35, time point 1

source_name: Patient 35 PBMC, collected at time point 1


title: Patient 32, time point 2

source_name: Patient 32 PBMC, collected at time point 2


title: Patient 26, time point 1

source_name: Patient 26 PBMC, collected at time point 1


title: Patient 26, time point 2

source_name: Patient 26 PBMC, collected at time point 2


title: Patient 29, time point 3

source_name: Patient 29 PBMC, collected at time point 3


title: Patient 23, time point 2

source_name: Patient 23 PBMC, collected at time point 2


title: Patient 23, time point 4

source_name: Patient 23 PBMC, collected at time point 4


title: Patient 17, time point 3

source_name: Patient 17 PBMC, collected at time point 3


title: Patient 29, time point 2

source_name: Patient 29 PBMC, collected at time point 2


title: Patient 23, time point 3

source_name: Patient 23 PBMC, collected at time point 3


title: Patient 26, time point 3

source_name: Patient 26 PBMC, collected at time point 3


title: Patient 17, time point 4

source_name: Patient 17 PBMC, collected at time point 4


title: Patient 17, time point 1

source_name: Patient 17 PBMC, collected at time point 1


title: Patient 26, time point 4

source_name: Patient 26 PBMC, collected at time point 4


title: Patient 17, time point 2

source_name: Patient 17 PBMC, collected at time point 2


title: Patient 35, time point 2

source_name: Patient 35 PBMC, collected at time point 2


title: Patient 23, time point 1

source_name: Patient 23 PBMC, collected at time point 1


title: Patient 11, time point 1

source_name: Patient 11 PBMC, collected at time point 1


title: Patient 11, time point 4

source_name: Patient 11 PBMC, collected at time point 4


title: Patient 08, time point 4

source_name: Patient 08 PBMC, collected at time point 4


title: Patient 08, time point 2

source_name: Patient 08 PBMC, collected at time point 2


title: Patient 08, time point 3

source_name: Patient 08 PBMC, collected at time point 3


title: Patient 08, time point 1

source_name: Patient 08 PBMC, collected at time point 1


title: 731274

source_name: Bone marrow specimen from Tumor cells

value: AA


title: PB_DON097

status: Public on Nov 01 2007

city: Seattle

first: Derek

middle: L

last: Stirewalt

state: WA

address: 1100 Fairview Ave N, D5-112

department: Clinical Research Division

institute: Fred Hutchinson Cancer Research Center

hyb_protocol: Hybridization was performed according to Affymetrix protocol.

scan_protocol: Arrays were scanned according to Affymetrix protocol.

data_processing: .DAT files were generated using GCOS 1.2.1 software (Affymetrix). CEL files were generated using MAS 5.0 softare (Affymetrix) with target signals for probe sets scaled to 500. Log2 expression values for individual probe sets were generated from .CEL files via robust multi-array average (gcRMA).

label: Biotin

source_name: Peripheral Blood Mononuclear Cells

label_protocol: Target was labeled with Enzo BioArray High Yield RNA Trascript Labeling Kit (Enzo Life TEchnologies, Farmingdale, NY) according to manufacturer's protocol.

extract_protocol: Total RNA extracted using TRIzol reagent (Invitrogen, Carlsbad, CA)according to manufacturer's protocol.

tag: Peripheral Blood Mononuclear Cells

tag: Unknown Age and Gender


title: PBSC_CD34_R000001

source_name: PBSC CD34 selected cells

tag: CD34 selected cells from G-CSF mobilized PBSC

tag: 41 yo Male


title: PB_DON102


title: PBSC_CD34_R000005

tag: 27 yo Male


title: PBSC_CD34_R000036

source_name: PBSC CD34 Selected cells

tag: 24 yo Male


title: PB_DON086


title: PBSC_CD34_K015567


title: PB_DON088


title: PB_DON056


title: PBSC_CD34_K015367

tag: 30 yo Female


title: FHCRCAML169020

source_name: Leukemia

tag: Diagnosis

value: AML M1

tag: Age

tag: Gender

value: Male

tag: Blast %

tag: Source

value: PB

tag: Cyto

tag: FLT3 ITD

tag: FLT3 TKD

value: No data


title: PBSC_CD34_KO14465

tag: 30 yo Male


title: PB_DON034


title: PB_DON058


title: PBSC_CD34_R000029

tag: 41 yo Female


title: PB_DON005

tag: Peripheral Blood Mononuclear Cells

tag: unknown age and gender


title: PBSC_CD34_R000012-2

tag: CD34 selected cells from G-CSF mobilized PBSC

tag: 49 yo Female


title: PBSC_CD34_K015430

tag: 42 yo Male


title: PBSC_CD34_R000023

tag: 36 yo Male


title: PB_DON046

tag: Unknown Age and Gender


title: PB_DON040


title: FHCRCAML16907

tag: Diagnosis

value: AML M5

value: No Data


title: FHCRCAML169016

value: ET/AML

tag: Age

value: Complex


title: FHCRCAML7216

value: MDS/AML

tag: Gender

value: Female


title: FHCRCAML4653

value: AML M2

tag: Blast %


title: FHCRCAML169018

tag: Source

value: BM


title: FHCRCAML7209

tag: Cyto


title: FHCRCAML2619

value: AML M4

tag: FLT3 ITD


title: FHCRCAML169011

value: Secondary AML

tag: FLT3 TKD


title: FHCRCAML169014


title: FHCRCAML1355


title: FHCRCAML169017


title: FHCRCAML16908

source_name: Leukemai


title: FHCRCAML2852


title: FHCRCAML16906


title: FHCRCAML1818


title: FHCRCAML4500

tag: Diagnosis:AML M2

value: INV9, INV14


title: FHCRCAML1970


title: FHCRCAML2429


title: FHCRCAML3653


title: FHCRCAML2557

tag: Sourc


title: FHCRCAML_2762

value: Normal


title: BM_CD34_TBO2854

source_name: Bone Marrow CD34+ selected cells

tag: Bone Marrow CD34+ selected cells

tag: 18y Male


title: BM_CD34_TBO2841

tag: 36y Male


title: FHCRCAML723

value: AML M0


title: BM_CD34_TBO3077

tag: 32y Male


title: FHCRCAML72


title: Patient 36, time point 1

source_name: Patient 36 PBMC, collected at time point 1

tag: Time

value: one week prior to commencement of periodontal therapy

tag: Tissue

value: Peripheral blood monocytes

tag: Phenotype

value: severe periodontitis


title: BM_CD34_TBO2249

tag: 23y Female


title: FHCRCAML482

tag: Diagnosis

tag: Age

value: Male

value: PB


title: BM_02879

source_name: Bone Marrow

tag: Bone Marrow Mononuclear Cells

tag: 22y Male


title: BM_030065

tag: 44y Female


title: BM_02619

tag: 35y Male


title: BM_02347

tag: 26y Female


title: BM_CD34_R000121

tag: 51y Male


title: FHCRCAML1038

value: AML M5

tag: Gender

tag: Blast %

tag: Source

tag: Cyto

tag: FLT3 ITD

tag: FLT3 TKD


title: BM_02300

tag: 31y Male


title: BM_CD34_TBO3488

tag: Bone Marrow CD34+ selected cells

tag: 23y Male


title: BM_02496

tag: 24y Male


title: BM_02680

tag: 24y Female


title: BM_02417

tag: Bone Marrow Mononuclear Cells

tag: Unknown Age/Unknown Gender


title: BM_CD34_TBO2523

tag: 16y Male


title: BM_02303

tag: 27y Male


title: BM_01000

tag: Unknown Age

tag: Unknown Gender


title: PBMCs-Type 2 Diabetes-T2D_2_New

status: Public on Sep 12 2007

city: Dallas

first: Ellen

last: Grishman

address: 5323 Harry Hines Blvd

institute: UTSW Medical Center

scan_protocol: GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 System.

data_processing: The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 500.

source_name: PBMCs from Type 2 Diabetes patient and the timepoint at diagnosis.

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol.

extract_protocol: RNeasy Mini

tag: Age

value: 9 yrs, when sample taken.

tag: Gender

value: F

tag: Ethnicity

value: Not Hispanic or Latino

tag: Race

value: Black or African American

tag: Illness

value: Type 2 Diabetes

tag: Treatment

value: Insulin

tag: pH<7.30 at time of diagnosis

value: No


title: PBMCs-Type 2 Diabetes-T2D11_T2D

description: Type 2 Diabetes patient and the timepoint at diagnosis.

value: 12 yrs, when sample taken.

value: M


title: PBMCs-Type 2 Diabetes-T2D_1_New

value: 17 yrs, when sample taken.

value: Hispanic or Latino

value: (Race Not Reported)


title: PBMCs-Type 2 Diabetes-T2D_7_New

value: 13 yrs, when sample taken.


title: PBMCs-Type 2 Diabetes-T2D_10_New

value: White


title: PBMCs-Type 2 Diabetes-T2D9_T2D

value: Yes


title: PBMCs-Type 2 Diabetes-T2D_4_New

value: 15 yrs, when sample taken.


title: PBMCs-Type 2 Diabetes-T2D_6_New


title: Patient 11, time point 3

source_name: Patient 11 PBMC, collected at time point 3

tag: Time

value: six weeks after commencement of periodontal therapy (after treatment end)

tag: Tissue

value: Peripheral blood monocytes

tag: Phenotype

value: severe periodontitis


title: PBMCs-Healthy-INF447_Healthy

description: Healthy patient.

source_name: PBMCs from Healthy patient.

value: 24 mths, when sample taken.

value: (Ethnicity Not Reported)

value: Healthy


title: PBMCs-Type 2 Diabetes-T2D_5_New

value: 14 yrs, when sample taken.

value: Not Hispanic or Latino

value: Asian

value: Type 2 Diabetes

value: Insulin


title: BM_CD34_R000030

hyb_protocol: Hybridization was performed according to Affymetrix  protocol.

tag: Bone Marrow CD34+ selected cells

tag: Unknown age/Male


title: PBMCs-Type 2 Diabetes-T2D_8_New

value: 11 yrs, when sample taken.

value: F

value: Black or African American

value: No


title: PBMCs-Type 1 Diabetes-IDDM61_T1D_4MO

source_name: PBMCs from Type 1 Diabetes patient and the timepoint 4 months after diagnosis.

value: 6 yrs, when sample taken.

value: Hispanic or Latino

value: (Race Not Reported)

value: Type 1 Diabetes

value: Yes


title: PBMCs-Type 2 Diabetes-T2D_13_New

value: 13 yrs, when sample taken.

value: M


title: PBMCs-Healthy-INF301_Healthy

description: Healthy patient.

value: 8 yrs, when sample taken.

value: White

value: Healthy


title: PBMCs-Type 1 Diabetes-IDDM56_T1D_New

source_name: PBMCs from Type 1 Diabetes patient and the timepoint at diagnosis.

value: 7 yrs, when sample taken.

value: Not Hispanic or Latino


title: PBMCs-Type 1 Diabetes-IDDM8_T1D_New

description: Type 1 Diabetes patient and the timepoint at diagnosis.

value: 12 yrs, when sample taken.

value: Insulin


title: PBMCs-Healthy-INF448_Healthy

description: Healthy patient.

value: 24 mths, when sample taken.

value: F


title: PBMCs-Healthy-INF408_Healthy

description: Healthy patient.

value: 2 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM61_T1D_New

value: 6 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM61_T1D_1MO

source_name: PBMCs from Type 1 Diabetes patient and the timepoint 1 month after diagnosis.

value: Hispanic or Latino


title: PBMCs-Type 1 Diabetes-IDDM59_T1D_4MO

description: Type 1 Diabetes patient and the timepoint 4 months after diagnosis.

value: (Race Not Reported)


title: PBMCs-Type 1 Diabetes-IDDM9_T1D_New

value: 16 yrs, when sample taken.

value: Type 1 Diabetes


title: PBMCs-Type 1 Diabetes-IDDM56_T1D_4MO

value: No


title: PBMCs-Type 1 Diabetes-IDDM59_T1D_New

value: Yes


title: PBMCs-Type 1 Diabetes-IDDM6_T1D_New

value: 8 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM57_T1D_New

value: 5 yrs, when sample taken.

value: White


title: PBMCs-Type 1 Diabetes-IDDM57_T1D_1MO

description: Type 1 Diabetes patient and the timepoint 1 month after diagnosis.


title: PBMCs-Type 1 Diabetes-IDDM57_T1D_4MO


title: PBMCs-Type 1 Diabetes-IDDM56_T1D_1MO

value: 7 yrs, when sample taken.

value: M


title: PBMCs-Type 1 Diabetes-IDDM54_T1D_1MO


title: PBMCs-Type 1 Diabetes-IDDM53_T1D_New

value: 13 yrs, when sample taken.

value: Not Hispanic or Latino


title: PBMCs-Type 1 Diabetes-IDDM53_T1D_4MO

value: 14 yrs, when sample taken.

value: Insulin


title: PBMCs-Type 1 Diabetes-IDDM54_T1D_4MO

value: F


title: PBMCs-Type 1 Diabetes-IDDM50_T1D_4MO


title: PBMCs-Type 1 Diabetes-IDDM50_T1D_New

value: 12 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM48_T1D_1MO

value: (Ethnicity Not Reported)


title: PBMCs-Type 1 Diabetes-IDDM53_T1D_1MO


title: PBMCs-Type 1 Diabetes-IDDM50_T1D_1MO


title: PBMCs-Type 1 Diabetes-IDDM52_T1D_4MO


title: PBMCs-Type 1 Diabetes-IDDM5_T1D_New

value: 9 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM55_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM47_T1D_New

value: 6 yrs, when sample taken.

value: Other


title: PBMCs-Type 1 Diabetes-IDDM47_T1D_1MO

value: Type 1 Diabetes

value: No


title: PBMCs-Type 1 Diabetes-IDDM54_T1D_New

value: Hispanic or Latino

value: (Race Not Reported)


title: PBMCs-Type 1 Diabetes-IDDM46_T1D_New

value: White


title: PBMCs-Type 1 Diabetes-IDDM52_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM48_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM46_T1D_4MO

value: 7 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM45_T1D_4MO

value: 3 yrs, when sample taken.

value: M

value: Yes


title: PBMCs-Type 1 Diabetes-IDDM45_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM43_T1D_New

value: 15 yrs, when sample taken.

value: Not Hispanic or Latino


title: PBMCs-Type 1 Diabetes-IDDM45_T1D_1MO

value: Insulin


title: PBMCs-Type 1 Diabetes-IDDM47_T1D_4MO


title: PBMCs-Type 1 Diabetes-IDDM43_T1D_4MO


title: PBMCs-Type 1 Diabetes-IDDM42_T1D_4MO

value: 11 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM41_T1D_4MO

value: 14 yrs, when sample taken.

value: F

value: Black or African American


title: PBMCs-Type 1 Diabetes-IDDM41_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM39_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM43_T1D_1MO


title: PBMCs-Type 1 Diabetes-IDDM4_T1D_New

value: 10 yrs, when sample taken.

value: Selected More than One Race


title: PBMCs-Type 1 Diabetes-IDDM41_T1D_1MO

value: Type 1 Diabetes


title: PBMCs-Type 1 Diabetes-IDDM38_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM39_T1D_4MO

value: 12 yrs, when sample taken.

value: No


title: PBMCs-Type 1 Diabetes-IDDM39_T1D_1MO

value: White


title: PBMCs-Type 1 Diabetes-IDDM32_T1D_1MO


title: PBMCs-Type 1 Diabetes-IDDM34_T1D_4MO


title: PBMCs-Type 1 Diabetes-IDDM37_T1D_New

value: 9 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM27_T1D_4MO

value: 8 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM3_T1D_New

value: M


title: PBMCs-Type 1 Diabetes-IDDM30_T1D_1MO

value: 7 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM23_T1D_New

value: 6 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM30_T1D_New

value: Not Hispanic or Latino


title: PBMCs-Type 1 Diabetes-IDDM27_T1D_New

value: Insulin


title: PBMCs-Type 1 Diabetes-IDDM34_T1D_1MO

value: Yes


title: PBMCs-Type 1 Diabetes-IDDM25_T1D_New

value: 15 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM27_T1D_1MO

value: F


title: PBMCs-Type 1 Diabetes-IDDM24_T1D_New

value: 2 yrs, when sample taken.

value: Black or African American


title: PBMCs-Type 1 Diabetes-IDDM30_T1D_4MO


title: PBMCs-Type 1 Diabetes-IDDM22_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM20_T1D_New


title: PBMCs-Type 1 Diabetes-IDDM14_T1D_New

value: 10 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM17_T1D_New

value: 5 yrs, when sample taken.

value: Hispanic or Latino

value: (Race Not Reported)

value: Type 1 Diabetes


title: PBMCs-Type 1 Diabetes-IDDM18_T1D_New

value: 13 yrs, when sample taken.

value: White

value: No


title: PBMCs-Type 1 Diabetes-IDDM34_T1D_New

value: 12 yrs, when sample taken.

value: M


title: PBMCs-Type 1 Diabetes-IDDM16_T1D_New

value: 17 yrs, when sample taken.


title: PBMCs-Type 1 Diabetes-IDDM15_T1D_New

value: Not Hispanic or Latino

value: Insulin


title: PBMCs-Type 1 Diabetes-IDDM19_T1D_New

value: 3 yrs, when sample taken.


title: PBMCs-Healthy-HIDDM4_Healthy

description: Healthy patient.

value: 14 yrs, when sample taken.

value: F

value: Healthy


title: PBMCs-Healthy-H98_Healthy

description: Healthy patient.

value: 16 yrs, when sample taken.

value: (Ethnicity Not Reported)


title: PBMCs-Healthy-H48_Healthy

description: Healthy patient.


title: PBMCs-Type 1 Diabetes-IDDM1_T1D_New

value: 9 yrs, when sample taken.

value: Yes


title: PBMCs-Healthy-H37_Healthy

description: Healthy patient.

value: (Race Not Reported)


title: PBMCs-Healthy-HIDDM2_Healthy

description: Healthy patient.

value: Hispanic or Latino

value: Selected More than One Race


title: PBMCs-Healthy-H42_Healthy

description: Healthy patient.

value: 8 yrs, when sample taken.


title: PBMCs-Healthy-H152_Healthy

description: Healthy patient.


title: PBMCs-Healthy-H166_Healthy

description: Healthy patient.


title: PBMCs-Healthy-H178_Healthy

description: Healthy patient.

value: 11 yrs, when sample taken.


title: PBMCs-Healthy-H126_Healthy

description: Healthy patient.

value: 15 yrs, when sample taken.

value: White


title: PBMCs-Healthy-H148_Healthy

description: Healthy patient.


title: PBMCs-Healthy-H125_Healthy

description: Healthy patient.

value: M


title: PBMCs-Healthy-H28_Healthy

description: Healthy patient.

value: 13 yrs, when sample taken.


title: PBMCs-Healthy-H176_Healthy

description: Healthy patient.


title: PBMCs-Healthy-H133_Healthy

description: Healthy patient.

value: 6 yrs, when sample taken.


title: PBMCs-Healthy-H149_Healthy

description: Healthy patient.


title: PBMCs-Healthy-H124_Healthy

description: Healthy patient.


title: PAD_00330_sample 27_preparation C_replicate 3

status: Public on May 31 2007

city: Padova

first: Andrea

last: Zangrando

address: Via Giustiniani, 3

department: Woman and Child's Health

country: Italy

institute: University of Padova

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 27
c-ALL/Pre-B-ALL with out t(9;22)

hyb_protocol: Following fragmentation, 11 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450DX.

scan_protocol: GeneChips were scanned using the Scan GCS3000Dx.

data_processing: The data were analyzed using R software [www.r-project.org] with BioConductor package [www.bioconductor.org] and Partek Genomics Suite software [www.partek.com].

source_name: White blood human cells

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

extract_protocol: Lysis of the mononuclear cells followed by lysate homonogenization using a biopolymer shredding system in a microcentrifuge spin-column format followed by total RNA purification using selective binding columns (method A); Trizol extraction of total RNA was performed according to the manufacturer's instructions (method B); Trizol extraction of total RNA followed by purification step was performed according to the manufacturer's instructions (method C).

treatment_protocol: White blood cells were isolated through Ficoll-Hypaque density gradient centrifugation (for ALL samples) or through hemolysis (for AML samples)

tag: Leukemia samples

tag: Bone Marrow sample


title: PBMCs-Healthy-H150_Healthy

description: Healthy patient.

value: 12 yrs, when sample taken.


title: PAD_00329_sample 27_preparation C_replicate 2


title: PBMCs-Healthy-H122_Healthy

description: Healthy patient.

value: F


title: PAD_00317_sample 26_preparation B_replicate 2

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 26
AML with t(11q23)/MLL

tag: Peripheral blood sample


title: PAD_00315_sample 26_preparation A_replicate 3


title: PAD_00314_sample 26_preparation A_replicate 2


title: PAD_00324_sample 27_preparation A_replicate 3


title: PAD_00316_sample 26_preparation B_replicate 1


title: PAD_00327_sample 27_preparation B_replicate 3


title: PAD_00326_sample 27_preparation B_replicate 2


title: PAD_00328_sample 27_preparation C_replicate 1


title: PAD_00323_sample 27_preparation A_replicate 2


title: PAD_00319_sample 26_preparation C_replicate 3


title: PAD_00313_sample 26_preparation A_replicate 1


title: PAD_00321_sample 26_preparation C_replicate 2


title: PAD_00320_sample 26_preparation C_replicate 1


title: PAD_00325_sample 27_preparation B_replicate 1


title: PAD_00333_sample 25_preparation B_replicate 3


title: PAD_00311_sample 25_preparation C_replicate 2

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 25
AML with normal karyotype + other abnormalities


title: PAD_00322_sample 27_preparation A_replicate 1


title: PAD_00308_sample 25_preparation B_replicate 2


title: PAD_00303_sample 24_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 24
c-ALL/Pre-B-ALL with out t(9;22)


title: PAD_00305_sample 25_preparation A_replicate 2


title: PAD_00309_sample 25_preparation B_replicate 3


title: PAD_00295_sample 24_preparation B


title: PAD_00302_sample 23_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 23
c-ALL/Pre-B-ALL with out t(9;22)


title: PAD_00310_sample 25_preparation C_replicate 1


title: PAD_00307_sample 25_preparation B_replicate 1


title: PAD_00304_sample 25_preparation A_replicate 1


title: PAD_00294_sample 23_preparation B


title: PAD_00287_sample 24_preparation A


title: PAD_00286_sample 23_preparation A


title: PAD_00293_sample 22_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 22
c-ALL/Pre-B-ALL with out t(9;22)


title: PAD_00306_sample 25_preparation A_replicate 3


title: PAD_00332_sample 25_preparation C_replicate 3


title: PAD_00301_sample 22_preparation C


title: PAD_00285_sample 22_preparation A


title: PAD_00300_sample 21_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 21
T-ALL


title: PAD_00282_sample 19_preparation A

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 19
ALL with hyperdiploid karyotype


title: PAD_00290_sample 19_preparation B


title: PAD_00292_sample 21_preparation B


title: PAD_00297_sample 18_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 18
T-ALL


title: PAD_00291_sample 20_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 20
c-ALL/Pre-B-ALL with out t(9;22)


title: PAD_00284_sample 21_preparation A


title: PAD_00289_sample 18_preparation B


title: PAD_00283_sample 20_preparation A


title: PAD_00281_sample 18_preparation A


title: PAD_00298_sample 19_preparation C


title: PAD_00296_sample 17_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 17
T-ALL


title: PAD_00299_sample 20_preparation C


title: PAD_00288_sample 17_preparation B


title: PAD_00271_sample 16_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 16
AML with t(11q23)/MLL


title: PAD_00263_sample 16_preparation A


title: PAD_00269_sample 14_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 14
c-ALL/Pre-B-ALL with out t(9;22)


title: PAD_00270_sample 15_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 15
ALL with t(12;21)


title: PAD_00280_sample 17_preparation A


title: PAD_00277_sample 14_preparation C


title: PAD_00262_sample 15_preparation A


title: PAD_00279_sample 16_preparation C


title: PAD_00268_sample 13_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 13
c-ALL/Pre-B-ALL with out t(9;22)


title: PAD_00261_sample 14_preparation A


title: PAD_00260_sample 13_preparation A


title: PAD_00274_sample 11_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 11
ALL with t(12;21)


title: PAD_00276_sample 13_preparation C


title: PAD_00275_sample 12_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 12
ALL with hyperdiploid karyotype


title: PAD_00278_sample 15_preparation C


title: PAD_00267_sample 12_preparation B


title: PAD_00259_sample 12_preparation A


title: PAD_00266_sample 11_preparation B


title: PAD_00258_sample 11_preparation A


title: PAD_00340_sample 10_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 10
T-ALL


title: PAD_00239_sample 8_preparation A

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 8
AML with normal karyotype + other abnormalities


title: PAD_00273_sample 10_preparation C


title: PAD_00247_sample 8_preparation B


title: PAD_00254_sample 7_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 7
c-ALL/Pre-B-ALL with t(9;22)


title: PAD_00255_sample 8_preparation C


title: PAD_00264_sample 9_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 9
c-ALL/Pre-B-ALL with t(9;22)


title: PAD_00246_sample 7_preparation B


title: PAD_00257_sample 10_preparation A


title: PAD_00236_sample 5_preparation A

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 5
ALL with t(1;19)


title: PAD_00272_sample 9_preparation C


title: PAD_00237_sample 6_preparation A

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 6
ALL with hyperdiploid karyotype


title: PAD_00244_sample 5_preparation B


title: PAD_00251_sample 4_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 4
ALL with t(12;21)


title: PAD_00252_sample 5_preparation C


title: PAD_00242_sample 3_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 3
T-ALL


title: PAD_00245_sample 6_preparation B


title: PAD_00253_sample 6_preparation C


title: PAD_00238_sample 7_preparation A


title: PAD_00331_sample 4_preparation A


title: PAD_00250_sample 3_preparation C


title: PAD_00249_sample 2_preparation C

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 2
c-ALL/Pre-B-ALL with t(9;22)


title: PAD_00234_sample 3_preparation A


title: PAD_00243_sample 4_preparation B


title: PAD_00241_sample 2_preparation B


title: PAD_00233_sample 2_preparation A


title: PBMC_S.aureus_MRSA_INF315

status: Public on Mar 16 2007

first: Damien

last: Chaussabel

address: 3434 Live Oak

institute: Baylor Institute for Immunology Research

description: The subject was infected with S. aureus, MRSA.

hyb_protocol: Standard Affymetrix protocol.

scan_protocol: GeneChips were scanned using the Agilent GeneArray 2500 Scanner.

source_name: PBMC_S. aureus

extract_protocol: RNeasy mini

value: 3 y, when sample taken

value: Hispanic

value: Cellulitis

value: Vancomycin

tag: Pathogen

value: S. aureus, MRSA


title: PBMC_S.pneumoniae_INF289_j6962833

description: The subject was infected with S. pneumoniae.

source_name: PBMC_S. pneumoniae

value: 2 y, when sample taken

value: Pneumonia/Empyema

value: Ceftriaxone/Vancomycin

value: S. pneumoniae


title: PAD_00240_sample 1_preparation B

description:
Gene expression data from pediatric acute leukemia samples at diagnosis
Patient 1
Pro-B-ALL with t(11q23)/MLL


title: PAD_00248_sample 1_preparation C


title: PBMC_S.pneumoniae_INF287_j8790090

value: 3y, when sample taken

value: Caucasian

value: Pneumonia/Bacteremia


title: PAD_00232_sample 1_preparation A


title: PBMC_S.aureus_MRSA_INF281

value: Osteomyelitis

value: Clindamycin


title: PBMC_S.pneumoniae_INF268_j5294684

value: M

value: Ceftriaxone/Clindamycin


title: PBMC_S.pneumoniae_INF277_j4695042

value: 16y, when sample taken


title: PBMC_InfluenzaA_INF266

description: The subject was infected with Influenza A.

value: 36y, when sample taken

value: F

value: Fever

value: Influenza A


title: PBMC_Healthy_INF25N

description: The subject was Healthy.

value: 11m, when sample taken

value: Hispanic

value: Healthy


title: PBMC_Healthy_INF27N

description: The subject was Healthy.

value: 10m, when sample taken


title: PBMC_S.pneumoniae_INF265_j7657238

value: 2 y, when sample taken

value: Pneumonia/Empyema

value: Ceftriaxone/Vancomycin

value: S. pneumoniae


title: PBMC_InfluenzaA_INF259

value: 3m, when sample taken

value: Pneumonia


title: PBMC_S.pneumoniae_INF261

value: 13y, when sample taken

value: M

value: Caucasian

value: Meningitis


title: PBMC_E.coli_INF229

description: The subject was infected with E. coli.

value: 4 m, when sample taken

value: F

value: UTI/bacteremia

value: Ceftriaxone

value: E. coli


title: PBMC_E.coli_INF222

description: The subject was infected with E. coli.

source_name: PBMC_E. coli

value: 3 m, when sample taken

value: Hispanic

value: Ceftriaxone/Gentamicin


title: PBMC_S.aureus_MSSA_INF206

description: The subject was infected with S. aureus, MSSA.

value: 1 y, when sample taken

value: Abscess

value: Clindamycin

value: S. aureus, MSSA


title: PBMC_Healthy_INF20N

description: The subject was Healthy.

value: 11m, when sample taken

value: Healthy


title: PBMC_E.coli_INF219

description: The subject was infected with E. coli.

value: 5 m, when sample taken


title: PBMC_Healthy_INF204

description: The subject was Healthy.

value: 2 y, when sample taken

value: M

value: Caucasian


title: PBMC_Healthy_INF19N

description: The subject was Healthy.

value: 4m, when sample taken


title: PBMC_E.coli_INF183

description: The subject was infected with E. coli.

value: 1.5m, when sample taken

value: UTI

value: Ampicillin/Gentamicin/Ceftriaxone


title: PBMC_E.coli_INF188

description: The subject was infected with E. coli.

value: E. coli


title: PBMC_E.coli_INF184

description: The subject was infected with E. coli.

value: 0.5m, when sample taken

value: F

value: UTI/bacteremia

value: Gentamicin/Ampicillin


title: PBMC_E.coli_INF197

description: The subject was infected with E. coli.

value: 1.25m, when sample taken


title: PBMC_E.coli_INF180

description: The subject was infected with E. coli.

value: 1 m, when sample taken

value: Hispanic


title: PBMC_E.coli_INF154

description: The subject was infected with E. coli.

value: 2 m, when sample taken

value: Ceftriaxone


title: PBMC_E.coli_INF175

description: The subject was infected with E. coli.


title: PBMC_S.aureus_MRSA_INF150

value: 9 y, when sample taken

value: Black

value: Osteomyelitis/bacteremia

value: Vancomycin/Rifampin

value: S. aureus, MRSA


title: PBMC_E.coli_INF152

description: The subject was infected with E. coli.

value: 2.5m, when sample taken

value: M

value: Bactermia

value: Ceftriaxone/Gentamicin


title: PBMC_E.coli_INF168

description: The subject was infected with E. coli.

value: 3 m, when sample taken

value: F

value: Caucasian

value: UTI

value: E. coli


title: PBMC_E.coli_INF139

description: The subject was infected with E. coli.

value: 1 m, when sample taken

value: Hispanic

value: Ampicillin/Ceftriaxone


title: PBMC_E.coli_INF161

description: The subject was infected with E. coli.

value: 1.7m, when sample taken


title: PBMC_Healthy_INF12N

description: The subject was Healthy.

value: 22m, when sample taken

value: Healthy


title: PBMC_E.coli_INF171

description: The subject was infected with E. coli.

value: Ceftriaxone


title: PBMC_E.coli_INF148

description: The subject was infected with E. coli.

value: 8y, when sample taken


title: PAD_00256_sample 9_preparation A


title: PBMC_E.coli_INF118

description: The subject was infected with E. coli.

value: 1.5m, when sample taken

value: Gentamicin/Ampicillin


title: PBMC_InfluenzaA_INF132

value: 6m, when sample taken

value: M

value: Resp distress

value: Oxacillin/Tobramycin

value: Influenza A


title: PBMC_S.pneumoniae_INF113

value: 7m, when sample taken

value: F

value: Septic arthritis

value: Ceftriaxone/Clindamycin

value: S. pneumoniae


title: PBMC_InfluenzaA_INF112

value: 1m, when sample taken

value: Hispanic

value: Fever

value: Ampicillin/Gentamicin


title: PBMC_E.coli_INF120

description: The subject was infected with E. coli.

value: UTI

value: Ampicillin/Ceftriaxone

value: E. coli


title: PBMC_InfluenzaA_INF128

value: 11m, when sample taken

value: Cefuroxime


title: PBMC_S.pneumoniae_INF155

value: 0.25y, when sample taken

value: M

value: Meningitis

value: Ceftriaxone/Vancomycin


title: PBMC_InfluenzaA_INF117

value: 24 y, when sample taken

value: F

value: Caucasian

value: Influenza A


title: PBMC_InfluenzaA_INF115

value: 20m, when sample taken

value: Seizures

value: Amoxicillin


title: PBMC_InfluenzaA_INF108

value: 5m, when sample taken

value: Hispanic

value: Fever

value: Ceftriaxone


title: PBMC_InfluenzaA_INF116

value: 2 y, when sample taken

value: Cefuroxime/Clindamycin


title: PBMC_InfluenzaA_INF114

value: 18m, when sample taken

value: Black

value: Cefuroxime/Oseltamivir


title: PBMC_InfluenzaA_INF092

value: 1m, when sample taken

value: Ampicillin/Ceftriaxone


title: PBMC_InfluenzaA_INF105

value: 4 y, when sample taken

value: F

value: Ceftriaxone/Acyclovir/Oseltamivir


title: PBMC_S.pneumoniae_INF096

value: 16 m, when sample taken

value: M

value: Pneumonia/Empyema

value: Ceftriaxone/Azithromycin

value: S. pneumoniae


title: PBMC_E.coli_INF133

description: The subject was infected with E. coli.

value: 2 m, when sample taken

value: Hispanic

value: UTI

value: E. coli


title: PBMC_InfluenzaA_INF107

value: 1.5m, when sample taken

value: Asian

value: Fever

value: Influenza A


title: PBMC_InfluenzaA_INF101

value: 4m, when sample taken

value: Cefuroxime/Oseltamivir


title: PBMC_InfluenzaA_INF095

value: 4 y, when sample taken


title: PBMC_InfluenzaA_INF104

value: 17m, when sample taken

value: Ceftriaxone


title: PBMC_InfluenzaA_INF087

value: 19m, when sample taken

value: F

value: Caucasian

value: Cefuroxime


title: PBMC_S.aureus_MRSA_INF070

value: 15m, when sample taken

value: Abscess

value: Vancomycin

value: S. aureus, MRSA


title: PBMC_S.aureus_MSSA_INF084

value: 18 y, when sample taken

value: Black

value: Abcess

value: Cefazolin

value: S. aureus, MSSA


title: PBMC_S.aureus_MRSA_INF089

value: 4m, when sample taken

value: Clindamycin


title: PBMC_S.aureus_MSSA_INF069

value: 9m, when sample taken

value: M

value: Hispanic

value: Lung abscess

value: Vancomycin/Cefazolin


title: PBMC_E.coli_INF074

description: The subject was infected with E. coli.

value: 4 m, when sample taken

value: F

value: UTI/bacteremia

value: Ceftriaxone

value: E. coli


title: PBMC_E.coli_INF048

description: The subject was infected with E. coli.

value: 2 m, when sample taken

value: Caucasian

value: UTI

value: Ampicillin/ceftriaxone


title: PBMC_E.coli_INF086

description: The subject was infected with E. coli.

value: 3 m, when sample taken


title: PBMC_E.coli_INF151

description: The subject was infected with E. coli.

value: 1.5m, when sample taken

value: Gentamicin/Ampicillin


title: PBMC_E.coli_INF057

description: The subject was infected with E. coli.

value: Black

value: Gentamicin


title: PBMC_S.pneumoniae_INF025

value: 2m, when sample taken

value: M

value: Hispanic

value: Meningitis

value: Ampicillin/Ceftriaxone

value: S. pneumoniae


title: PBMC_E.coli_INF012

description: The subject was infected with E. coli.

value: 5 m, when sample taken

value: Bacteremia

value: Ceftriaxone


title: PBMC_E.coli_INF013

description: The subject was infected with E. coli.

value: F

value: Caucasian

value: E. coli


title: PBMC_S.pneumoniae_INF009

tag: Age:4m, when sample taken

value: Abscess

value: Cefazolin


title: PBMC_S.pneumoniae_INF064

tag: Age

value: 10m, when sample taken

value: Meningitis/Bacteremia

value: Vancomycin/Ceftriaxone


title: PBMC_S.pneumoniae_INF041

value: 23m, when sample taken

tag: Gender

value: Pneumonia/Empyema


title: PBMC_E.coli_INF031

description: The subject was infected with E. coli.

value: 3 m, when sample taken

value: Hispanic

value: UTI

value: Gentamicin


title: PBMC_E.coli_INF034

description: The subject was infected with E. coli.

value: 16y, when sample taken

value: Pyelonephritis


title: PBMC_E.coli_INF082

description: The subject was infected with E. coli.

value: 2 m, when sample taken

value: M

value: Ampicillin/Ceftriaxone


title: ALLREZ.P51

status: Public on Sep 27 2006

city: Berlin

first: Renate

last: Kirschner-Schwabe

address: Augustenburger Platz 1

department: Pediatric Oncology/Hematology

country: Germany

institute: Charité - Universitätsmedizin Berlin

description: first relapse acute lymphocytic leukemia

data_processing: Probe level normalization: calibration and variance stabilization (Huber et al. PMID: 12169536).  Probe-set summarization: median polish on the normalized data (Irrizary et al. PMID: 12582260).

source_name: bone marrow (freshly isolated mononuclear cells)

tag: Age at relapse diagnosis [years]

tag: Sex

value: male

tag: Immunophenotype

value: pro-B

tag: Time of relapse

value: late

tag: Site of relapse

value: isolated BM

tag: ALL-REZ BFM risk group

value: intermediate (S2)

tag: Peripheral blast count at relapse diagnosis per microliter

tag: Minimal residual disease (after 2 induction cycles)

tag: Genetic features

value: not found

tag: S and G2/M phase cells [%]

tag: Frontline therapy

value: ALL-BFM 2000 MR


title: ALLREZ.P52

value: common

value: combined BM

value: high

value: TEL-AML1 positive

value: ALL-BFM 2000 SR


title: ALLREZ.P56

value: B-cell precursor


title: ALLREZ.P58

value: very early

value: high (S4)


title: ALLREZ.P57

value: early

value: high (S3)

value: COALL 06-97


title: ALLREZ.P55

value: male

value: pre-B

value: hyperdiploid


title: ALLREZ.P60

value: isolated BM

value: BCR-ABL positive

value: ALL-BFM 95 HR


title: ALLREZ.P54

value: female

value: late

value: intermediate (S2)

value: ALL-BFM 95 SR


title: ALLREZ.P50

value: T

value: not found

value: ALL-BFM 90 HRG


title: ALLREZ.P59

value: common

value: high


title: ALLREZ.P48

value: combined BM

value: low

value: ALL-BFM 86


title: ALLREZ.P49

value: male

value: pre-B

value: ALL-BFM 95 MR


title: ALLREZ.P53

value: B-cell precursor

value: very early

value: high (S4)

value: ALL-BFM 2000 MR


title: ALLREZ.P46

value: female

value: pre-T

value: isolated BM

value: ALL-BFM 2000 HR


title: ALLREZ.P47

value: late

value: intermediate (S2)

value: not found


title: ALLREZ.P45

source_name: peripheral blood (freshly isolated mononuclear cells)

value: pro-B

value: MLL-AF4 positive

value: ALL-BFM 2000 Interfant


title: ALLREZ.P43

value: male

value: common

value: low

value: TEL-AML1 positive

value: ALL-BFM 2000 SR


title: ALLREZ.P38

value: ALL-BFM 95 HR


title: ALLREZ.P42

source_name: bone marrow (cryopreserved mononuclear cells)

value: high

value: hyperdiploid

value: COALL 06-97


title: ALLREZ.P41

value: very early

value: isolated BM

value: high (S4)


title: ALLREZ.P40

value: pre-B

value: late

value: intermediate (S2)


title: ALLREZ.P44

value: female

value: B-cell precursor

value: not found

value: NHL-BFM 95


title: ALLREZ.P36

value: common

value: low

value: BCR-ABL positive

value: ALL-BFM 2000 HR


title: ALLREZ.P39

value: ALL-BFM 2000 MR


title: ALLREZ.P33

value: male

value: pro-B

value: MLL-AF4 positive

value: ALL-BFM 2000 Interfant


title: ALLREZ.P35

value: isolated BM

value: high

value: ALL-BFM 95 MR


title: ALLREZ.P37

value: pre-B

value: very early

value: high (S4)


title: ALLREZ.P34

value: female


title: ALLREZ.P32

value: pre-T

value: late

value: not found

value: AML-BFM 93


title: ALLREZ.P26

value: common

value: early

value: combined BM

value: intermediate (S2)

value: low


title: ALLREZ.P29

value: high (S3)

value: hyperdiploid

value: COALL 06-97


title: ALLREZ.P28

value: male

value: isolated BM


title: ALLREZ.P27

value: ALL-BFM 95 HR


title: ALLREZ.P30

value: T

value: high (S4)

value: ALL-BFM 2000 HR


title: PBMC_InfluenzaA_INF055

value: 11m, when sample taken

value: M

tag: Race

value: Hispanic

tag: Illness

value: Resp distress

tag: Treatment

value: Cefuroxime

value: Influenza A


title: ALLREZ.P31

value: pro-B

value: early

value: combined BM

value: intermediate (S2)

value: high

value: not found

value: ALL-BFM 2000 MR


title: ALLREZ.P25

value: female

value: pre-B

value: very early

value: isolated BM


title: ALLREZ.P22

value: male

value: high (S4)


title: ALLREZ.P23

value: T


title: ALLREZ.P17

value: common

value: late

value: hyperdiploid

value: ALL-BFM 95 MR


title: ALLREZ.P20

value: E2A-PBX1 positive

value: COALL 06-97


title: ALLREZ.P16

value: ALL-BFM 2000 HR


title: ALLREZ.P21

value: undefined


title: ALLREZ.P15

value: not found


title: ALLREZ.P10

value: intermediate (S2)

value: high


title: ALLREZ.P13

value: female

value: pro-B

value: early

value: high (S3)

value: ALL-BFM 95 SR


title: ALLREZ.P11

value: male

value: isolated BM

value: TEL-AML1 positive


title: ALLREZ.P9

value: common


title: ALLREZ.P19

value: T

value: very early

value: combined BM

value: high (S4)


title: ALLREZ.P24

value: pre-B

value: late

value: low

value: ALL-BFM 95 MR


title: ALLREZ.P18

value: female

value: not found

value: ALL-BFM 2000 MR


title: ALLREZ.P14

value: intermediate (S2)


title: ALLREZ.P8


title: ALLREZ.P12


title: ALLREZ.P6

value: high


title: ALLREZ.P7

value: male


title: ALLREZ.P5

value: isolated BM

value: ALL-BFM 95 SR


title: ALLREZ.P2

value: early

value: high (S3)

value: hyperdiploid

value: COALL 06-97


title: ALLREZ.P3

value: common

value: TEL-AML1 positive

value: ALL-BFM 2000 SR


title: ALLREZ.P4

value: late

value: low


title: ALLREZ.P1

value: pre-B

value: combined BM


title: amlrrays 3485

status: Public on Apr 15 2004

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg

source_name: blasts and mononuclear cells


title: amlrrays 2670

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays CD34#3

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=, Karyotype=, FLT3 ITD=, FLT3 TKD=, N-RAS=, K-RAS=, EVI1=, cEBPa=


title: amlrrays 2541

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=11q23, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3487

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=ND, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=pos, EVI1=neg, cEBPa=neg


title: amlrrays CD34#4


title: amlrrays 3329

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays NBM#6


title: amlrrays 3486

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3331

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays NBM#5


title: amlrrays 3488

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=Complex, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2669

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2772

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=11q23, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=pos, cEBPa=neg


title: amlrrays NBM#4


title: amlrrays NBM#2


title: amlrrays NBM#3


title: amlrrays 3484


title: amlrrays 3489

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3328


title: amlrrays 2771

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=pos, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2542

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=-7, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=pos, K-RAS=neg, EVI1=pos, cEBPa=neg


title: amlrrays 2767

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=ND, FLT3 ITD=neg, FLT3 TKD=pos, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2766

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=pos, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2769

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays CD34#5


title: amlrrays 3100

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3115

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3102

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=-7, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=pos, cEBPa=neg


title: amlrrays 3317

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3318

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=Complex, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3293

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M3, Karyotype=ND, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=pos, cEBPa=neg


title: amlrrays 2266

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M3, Karyotype="t(15;17)", FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3295

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype="t(8;21)", FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3101

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=pos, K-RAS=neg, EVI1=neg, cEBPa=pos


title: amlrrays 2283

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=+8, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2280

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2279

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2297

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M3, Karyotype="t(15;17)", FLT3 ITD=neg, FLT3 TKD=pos, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2511


title: amlrrays 3330


title: amlrrays 2293

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3304

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3319

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2255

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=11q23, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=pos, EVI1=neg, cEBPa=neg


title: amlrrays 3316

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=11q23, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2647

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=pos, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2749


title: amlrrays 2747

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=, Karyotype=, FLT3 ITD=, FLT3 TKD=, N-RAS=, K-RAS=, EVI1=, cEBPa=


title: amlrrays 3301

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=-7, FLT3 ITD=neg, FLT3 TKD=pos, N-RAS=pos, K-RAS=neg, EVI1=pos, cEBPa=neg


title: amlrrays 1188

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=-7, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2765

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2748

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=pos


title: amlrrays 1201

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=Complex, FLT3 ITD=neg, FLT3 TKD=pos, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 1197

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M0, Karyotype=Complex, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 1432

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 1063

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=pos, EVI1=neg, cEBPa=neg


title: amlrrays 1316

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=pos


title: amlrrays 2223

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 1401


title: amlrrays 1299

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 1482

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=pos, K-RAS=pos, EVI1=neg, cEBPa=neg


title: amlrrays 2211

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype="t(8;21)", FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 1448

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M3, Karyotype="t(15;17)", FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3492

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=pos, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 1551

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3493

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 2750

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3490


title: amlrrays 2215

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=pos, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3482

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3334

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=ND, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3332


title: amlrrays 3327


title: amlrrays 3333

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=NN, FLT3 ITD=pos, FLT3 TKD=neg, N-RAS=neg, K-RAS=pos, EVI1=neg, cEBPa=neg


title: amlrrays 3326

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M2, Karyotype=-7, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3483

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3491

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M1, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3325

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M4, Karyotype=NN, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3481


title: amlrrays 3322

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=11q23, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3320


title: amlrrays 3324

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M5, Karyotype=idt(16), FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3314

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=ND, Karyotype=Complex, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg


title: amlrrays 3313

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of acute myeloid patients. Samples contained 80-100 percent blast cells. Total RNA was extracted by lyses with guanidium isothiocyanate followed by cesium chloride gradient purification. FAB=M0, Karyotype=, FLT3 ITD=neg, FLT3 TKD=neg, N-RAS=neg, K-RAS=neg, EVI1=neg, cEBPa=neg